Irish Needle Exchange Forum
RSS icon Email icon Home icon
  • Request for Expressions of Interest: to carry out an Evaluation of the HSE Naloxone Demonstration Project

    Posted on April 2nd, 2015 TimB No comments

    The HSE has a stated commitment to take actions which focus on reducing the number of drug-related deaths and near-fatal drug poisonings. The HSE is currently finalising a Naloxone Demonstration Project, the purpose of which is to have Naloxone available for use by opioid users in order to prevent overdose. This project meets one of the key actions contained in the Primary Care Division Operational Plan 2015, “Implement a Naloxone Demonstration Project to assess and evaluate its suitability and impact (in line with NDS Action 40).”

    The demonstration project involves 600 patients receiving take-home Naloxone within the current legislative framework.  The product (Prenoxad 1mg/ml injection) is a licensed injectable administered via the parenteral route and formulated in a specific overdose pack. This allows for lay administration. The product is currently available inWales and England.

    A key element of the demonstration project is the provision of training for drug users and those close to them, on the use of Naloxone and on recognising and dealing with overdose events.


    Comments are closed.

Google Analytics integration offered by Wordpress Google Analytics Plugin